WallStreetZenWallStreetZen

NASDAQ: UBX
Unity Biotechnology Inc Stock Forecast, Predictions & Price Target

Analyst price target for UBX

Based on 2 analysts offering 12 month price targets for Unity Biotechnology Inc.
Min Forecast
$8.00+440.54%
Avg Forecast
$9.00+508.11%
Max Forecast
$10.00+575.68%

Should I buy or sell UBX stock?

Based on 2 analysts offering ratings for Unity Biotechnology Inc.
Buy
Strong Buy
0 analysts 0%
Buy
2 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their UBX stock forecasts and price targets.

UBX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-16
lockedlocked$00.00+00.00%2023-11-14

1 of 1

Forecast return on equity

Is UBX forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.16%

Forecast return on assets

Is UBX forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

UBX revenue forecast

What is UBX's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$27.3M
Avg 2 year Forecast
$27.8M
Avg 3 year Forecast
$58.5M

UBX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
UBX$1.48$9.00+508.11%Buy
SNSE$1.00$4.00+300.00%Buy
ONCT$8.25$34.00+312.12%Strong Buy
GDTC$2.20$5.00+127.27%Buy
PLUR$4.90N/AN/A

Unity Biotechnology Stock Forecast FAQ

Is Unity Biotechnology Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: UBX) stock is to Buy UBX stock.

Out of 2 analysts, 0 (0%) are recommending UBX as a Strong Buy, 2 (100%) are recommending UBX as a Buy, 0 (0%) are recommending UBX as a Hold, 0 (0%) are recommending UBX as a Sell, and 0 (0%) are recommending UBX as a Strong Sell.

If you're new to stock investing, here's how to buy Unity Biotechnology stock.

What is UBX's revenue growth forecast for 2025-2027?

(NASDAQ: UBX) Unity Biotechnology's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.04%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.92%.

Unity Biotechnology's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast UBX's revenue for 2025 to be $458,107,597, with the lowest UBX revenue forecast at $458,107,597, and the highest UBX revenue forecast at $458,107,597. On average, 1 Wall Street analysts forecast UBX's revenue for 2026 to be $467,340,252, with the lowest UBX revenue forecast at $467,340,252, and the highest UBX revenue forecast at $467,340,252.

In 2027, UBX is forecast to generate $982,690,315 in revenue, with the lowest revenue forecast at $982,690,315 and the highest revenue forecast at $982,690,315.

What is UBX's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: UBX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is UBX's Price Target?

According to 2 Wall Street analysts that have issued a 1 year UBX price target, the average UBX price target is $9.00, with the highest UBX stock price forecast at $10.00 and the lowest UBX stock price forecast at $8.00.

On average, Wall Street analysts predict that Unity Biotechnology's share price could reach $9.00 by Apr 16, 2025. The average Unity Biotechnology stock price prediction forecasts a potential upside of 508.11% from the current UBX share price of $1.48.

What is UBX's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: UBX) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.